You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Immunomodulators Market Research Report 2021 Professional Edition

Immunomodulators are referred to as the medications that are used for the regulation or for normalizing the immune system.
The global market for immunomodualtors is expected to grow exponentially over the forecast period owing to the rising cases of chronic diseases such as multiple sclerosis, allergic conditions, cancer, and asthma.
Market Analysis and Insights: Global Immunomodulators Market
The global Immunomodulators market size is projected to reach US$ 169150 million by 2027, from US$ 141150 million in 2020, at a CAGR of 3.1% during 2021-2027.
Global Immunomodulators Scope and Segment
The global Immunomodulators market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunomodulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Immunosuppressant
Immunostimulants
By the end users/application, this report covers the following segments
Oncology
Respiratory
HIV
Others
Competitive Landscape:
The report provides a list of all the key players in the Immunomodulators market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Immunomodulators key manufacturers in this market include:
Roche
Amgen Inc.
Abbott
Johnson & Johnson
Novartis AG
Eli Lilly and Company
Bristol-Myers Squibb Company
Merck & Co. Inc.
Biogen
1 Immunomodulators Market Overview
1.1 Immunomodulators Product Overview
1.2 Immunomodulators Market Segment by Type
1.2.1 Immunosuppressant
1.2.2 Immunostimulants
1.3 Global Immunomodulators Market Size by Type
1.3.1 Global Immunomodulators Market Size Overview by Type (2016-2027)
1.3.2 Global Immunomodulators Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Immunomodulators Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Immunomodulators Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Immunomodulators Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Immunomodulators Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Immunomodulators Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Immunomodulators Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Immunomodulators Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immunomodulators Sales Breakdown by Type (2016-2021)
1.4.2 Europe Immunomodulators Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Immunomodulators Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Immunomodulators Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Immunomodulators Sales Breakdown by Type (2016-2021)

2 Global Immunomodulators Market Competition by Company
2.1 Global Top Players by Immunomodulators Sales (2016-2021)
2.2 Global Top Players by Immunomodulators Revenue (2016-2021)
2.3 Global Top Players Immunomodulators Price (2016-2021)
2.4 Global Top Manufacturers Immunomodulators Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immunomodulators Market Competitive Situation and Trends
2.5.1 Immunomodulators Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Immunomodulators Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunomodulators as of 2020)
2.7 Date of Key Manufacturers Enter into Immunomodulators Market
2.8 Key Manufacturers Immunomodulators Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Immunomodulators Status and Outlook by Region
3.1 Global Immunomodulators Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Immunomodulators Historic Market Size by Region
3.2.1 Global Immunomodulators Sales in Volume by Region (2016-2021)
3.2.2 Global Immunomodulators Sales in Value by Region (2016-2021)
3.2.3 Global Immunomodulators Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Immunomodulators Forecasted Market Size by Region
3.3.1 Global Immunomodulators Sales in Volume by Region (2022-2027)
3.3.2 Global Immunomodulators Sales in Value by Region (2022-2027)
3.3.3 Global Immunomodulators Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Immunomodulators by Application
4.1 Immunomodulators Market Segment by Application
4.1.1 Oncology
4.1.2 Respiratory
4.1.3 HIV
4.1.4 Others
4.2 Global Immunomodulators Market Size by Application
4.2.1 Global Immunomodulators Market Size Overview by Application (2016-2027)
4.2.2 Global Immunomodulators Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Immunomodulators Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Immunomodulators Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Immunomodulators Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Immunomodulators Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Immunomodulators Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Immunomodulators Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Immunomodulators Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immunomodulators Sales Breakdown by Application (2016-2021)
4.3.2 Europe Immunomodulators Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Immunomodulators Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Immunomodulators Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Immunomodulators Sales Breakdown by Application (2016-2021)

5 North America Immunomodulators by Country
5.1 North America Immunomodulators Historic Market Size by Country
5.1.1 North America Immunomodulators Sales in Volume by Country (2016-2021)
5.1.2 North America Immunomodulators Sales in Value by Country (2016-2021)
5.2 North America Immunomodulators Forecasted Market Size by Country
5.2.1 North America Immunomodulators Sales in Volume by Country (2022-2027)
5.2.2 North America Immunomodulators Sales in Value by Country (2022-2027)

6 Europe Immunomodulators by Country
6.1 Europe Immunomodulators Historic Market Size by Country
6.1.1 Europe Immunomodulators Sales in Volume by Country (2016-2021)
6.1.2 Europe Immunomodulators Sales in Value by Country (2016-2021)
6.2 Europe Immunomodulators Forecasted Market Size by Country
6.2.1 Europe Immunomodulators Sales in Volume by Country (2022-2027)
6.2.2 Europe Immunomodulators Sales in Value by Country (2022-2027)

7 Asia-Pacific Immunomodulators by Region
7.1 Asia-Pacific Immunomodulators Historic Market Size by Region
7.1.1 Asia-Pacific Immunomodulators Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Immunomodulators Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Immunomodulators Forecasted Market Size by Region
7.2.1 Asia-Pacific Immunomodulators Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Immunomodulators Sales in Value by Region (2022-2027)

8 Latin America Immunomodulators by Country
8.1 Latin America Immunomodulators Historic Market Size by Country
8.1.1 Latin America Immunomodulators Sales in Volume by Country (2016-2021)
8.1.2 Latin America Immunomodulators Sales in Value by Country (2016-2021)
8.2 Latin America Immunomodulators Forecasted Market Size by Country
8.2.1 Latin America Immunomodulators Sales in Volume by Country (2022-2027)
8.2.2 Latin America Immunomodulators Sales in Value by Country (2022-2027)

9 Middle East and Africa Immunomodulators by Country
9.1 Middle East and Africa Immunomodulators Historic Market Size by Country
9.1.1 Middle East and Africa Immunomodulators Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Immunomodulators Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Immunomodulators Forecasted Market Size by Country
9.2.1 Middle East and Africa Immunomodulators Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Immunomodulators Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Immunomodulators Business
10.1 Roche
10.1.1 Roche Corporation Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Roche Immunomodulators Products Offered
10.1.5 Roche Recent Development
10.2 Amgen Inc.
10.2.1 Amgen Inc. Corporation Information
10.2.2 Amgen Inc. Introduction and Business Overview
10.2.3 Amgen Inc. Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Roche Immunomodulators Products Offered
10.2.5 Amgen Inc. Recent Development
10.3 Abbott
10.3.1 Abbott Corporation Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Abbott Immunomodulators Products Offered
10.3.5 Abbott Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Corporation Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Johnson & Johnson Immunomodulators Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Novartis AG
10.5.1 Novartis AG Corporation Information
10.5.2 Novartis AG Introduction and Business Overview
10.5.3 Novartis AG Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Novartis AG Immunomodulators Products Offered
10.5.5 Novartis AG Recent Development
10.6 Eli Lilly and Company
10.6.1 Eli Lilly and Company Corporation Information
10.6.2 Eli Lilly and Company Introduction and Business Overview
10.6.3 Eli Lilly and Company Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Eli Lilly and Company Immunomodulators Products Offered
10.6.5 Eli Lilly and Company Recent Development
10.7 Bristol-Myers Squibb Company
10.7.1 Bristol-Myers Squibb Company Corporation Information
10.7.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.7.3 Bristol-Myers Squibb Company Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Bristol-Myers Squibb Company Immunomodulators Products Offered
10.7.5 Bristol-Myers Squibb Company Recent Development
10.8 Merck & Co. Inc.
10.8.1 Merck & Co. Inc. Corporation Information
10.8.2 Merck & Co. Inc. Introduction and Business Overview
10.8.3 Merck & Co. Inc. Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merck & Co. Inc. Immunomodulators Products Offered
10.8.5 Merck & Co. Inc. Recent Development
10.9 Biogen
10.9.1 Biogen Corporation Information
10.9.2 Biogen Introduction and Business Overview
10.9.3 Biogen Immunomodulators Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Biogen Immunomodulators Products Offered
10.9.5 Biogen Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immunomodulators Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immunomodulators Industrial Chain Analysis
11.4 Immunomodulators Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immunomodulators Distributors
12.3 Immunomodulators Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140